Review
doi: 10.1016/s0065-230x(08)60900-8.
Virus augmentation of the antigenicity of tumor cell extracts
- PMID: 92181
- DOI: 10.1016/s0065-230x(08)60900-8
Item in Clipboard
Review
Virus augmentation of the antigenicity of tumor cell extracts
Adv Cancer Res.
1979.
No abstract available
Similar articles
-
Viral xenogenization of intact tumor cells.Adv Cancer Res. 1979;30:279-99. doi: 10.1016/s0065-230x(08)60899-4. Adv Cancer Res. 1979. PMID: 92180 Review. No abstract available.
-
Recent views on tumour antigens and their relation to host defence mechanisms.Aust N Z J Med. 1977 Oct;7(5):526-36. doi: 10.1111/j.1445-5994.1977.tb03377.x. Aust N Z J Med. 1977. PMID: 75001 No abstract available.
-
Molecular basis of the immunogenicity of cell surface tumor antigens.Exp Cell Biol. 1976;44(3-6):150-69. doi: 10.1159/000163109. Exp Cell Biol. 1976. PMID: 70384 No abstract available.
-
On the nature of tumour-specific transplantation-type antigens.Exp Cell Biol. 1976;44(3-6):184-97. doi: 10.1159/000163111. Exp Cell Biol. 1976. PMID: 1029663 No abstract available.
-
Possibilities for active immunotherapy of human cancer.Cancer Invest. 1992;10(4):285-93. doi: 10.3109/07357909209032753. Cancer Invest. 1992. PMID: 1378351 Review. No abstract available.
Cited by
-
Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.Cancer Immunol Immunother. 1986;22(3):221-31. doi: 10.1007/BF00200037. Cancer Immunol Immunother. 1986. PMID: 3460702 Free PMC article.
-
Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates.Cancer Immunol Immunother. 1987;25(3):257-65. doi: 10.1007/BF00199156. Cancer Immunol Immunother. 1987. PMID: 3677126 Free PMC article.
-
Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells.Oncol Lett. 2018 Jul;16(1):1180-1188. doi: 10.3892/ol.2018.8785. Epub 2018 May 22. Oncol Lett. 2018. PMID: 30061941 Free PMC article.
-
Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.Cancer Immunol Immunother. 1984;17(2):142-6. doi: 10.1007/BF00200051. Cancer Immunol Immunother. 1984. PMID: 6088033 Free PMC article.
-
Immune recognition of tumor cells in mice infected with Pichinde virus.Cancer Immunol Immunother. 1984;17(1):56-61. doi: 10.1007/BF00205498. Cancer Immunol Immunother. 1984. PMID: 6203637 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
